- Home
- ZLAB vs BWIN Comparison
ZLAB vs BWIN Comparison
Compare ZLAB & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- BWIN
- Stock Information
- Founded
- ZLAB 2013
- BWIN 2011
- Country
- ZLAB China
- BWIN United States
- Employees
- ZLAB N/A
- BWIN N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- BWIN Specialty Insurers
- Sector
- ZLAB Health Care
- BWIN Finance
- Exchange
- ZLAB Nasdaq
- BWIN Nasdaq
- Market Cap
- ZLAB 3.4B
- BWIN 2.9B
- IPO Year
- ZLAB 2017
- BWIN 2019
- Fundamental
- Price
- ZLAB $36.14
- BWIN $38.79
- Analyst Decision
- ZLAB Buy
- BWIN Buy
- Analyst Count
- ZLAB 3
- BWIN 7
- Target Price
- ZLAB $47.37
- BWIN $43.00
- AVG Volume (30 Days)
- ZLAB 1.3M
- BWIN 615.6K
- Earning Date
- ZLAB 05-07-2025
- BWIN 05-06-2025
- Dividend Yield
- ZLAB N/A
- BWIN N/A
- EPS Growth
- ZLAB N/A
- BWIN N/A
- EPS
- ZLAB N/A
- BWIN N/A
- Revenue
- ZLAB $398,988,000.00
- BWIN $1,389,037,000.00
- Revenue This Year
- ZLAB $45.57
- BWIN $13.39
- Revenue Next Year
- ZLAB $47.91
- BWIN $13.65
- P/E Ratio
- ZLAB N/A
- BWIN N/A
- Revenue Growth
- ZLAB 49.59
- BWIN 13.99
- 52 Week Low
- ZLAB $13.48
- BWIN $26.08
- 52 Week High
- ZLAB $37.99
- BWIN $55.82
- Technical
- Relative Strength Index (RSI)
- ZLAB 64.46
- BWIN 44.81
- Support Level
- ZLAB $34.32
- BWIN $37.55
- Resistance Level
- ZLAB $37.99
- BWIN $41.50
- Average True Range (ATR)
- ZLAB 1.98
- BWIN 2.07
- MACD
- ZLAB 0.02
- BWIN -0.08
- Stochastic Oscillator
- ZLAB 72.51
- BWIN 23.09
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About BWIN The Baldwin Insurance Group Inc. Class A Common Stock
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.